When T cells are activated by corresponding tumour antigens, they express surface activation markers such as 41BB, CD69 and CD25 and produce effector molecules such as IL-2, TNF-α, IFN-γ, perforin and granzymes [14, 15]. The gene discussed is PRF1; the disease is neoplasm.